4883 — Modalis Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for Modalis Therapeutics, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4,936 | 2,933 | 1,883 | 3,575 | 2,812 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5,067 | 3,061 | 1,956 | 3,617 | 2,892 |
| Net Property, Plant And Equipment | 224 | — | — | — | — |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 6,069 | 3,130 | 2,026 | 3,692 | 2,964 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 181 | 142 | 198 | 117 | 135 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 520 | 189 | 646 | 143 | 171 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 5,549 | 2,941 | 1,380 | 3,548 | 2,793 |
| Total Liabilities & Shareholders' Equity | 6,069 | 3,130 | 2,026 | 3,692 | 2,964 |
| Total Common Shares Outstanding |